Juno licenses gamma secretase inhibitor, related IP

By Jaime De Leon | Dec 8, 2017 | 9:02 PM GMT

Juno Therapeutics Inc. (NASDAQ:JUNO) announced a trio of licensing agreements to advance its multiple myeloma (MM)